Biotech, CROs, and medical device companies use VelorQ's Agents and Tools to accelerate research discovery and navigate multi-agency compliance across FDA, EMA, and CDSCO.
Literature surveillance, submission preparation, and cross-agency compliance all compete for scarce scientific and regulatory attention.
Keeping up with a fast-moving research literature — relevant studies, competitor filings, safety signals — is a full-time job on its own.
Biotech and device companies often submit into multiple jurisdictions at once, each with distinct evidentiary and format requirements.
Clinical trial sites and research partners generate a steady stream of process questions that pull scientific staff away from research.
AI Agents and Tools covering regulatory intelligence, research discovery, support, and analytics — all trained on life sciences domain knowledge.
Tracks multi-agency regulatory requirements and assembles submission-ready documentation across FDA, EMA, and CDSCO.
Learn More →Surfaces relevant literature, prior filings, and safety signals from a continuously growing body of research — in seconds.
Learn More →Handles routine investigator and partner queries around trial protocols and submission status, around the clock.
Learn More →Turns trial and regulatory data into dashboards that track submission health and research output over time.
Learn More →A biotech research team uses Discover to monitor new publications and competitor filings relevant to its pipeline, surfacing only what's materially relevant instead of a daily manual search.
A CRO uses RegIntel to reconcile FDA, EMA, and CDSCO requirements for a single device submission into one tracked plan, flagging where evidentiary requirements diverge.
Support fields routine trial-site questions about protocol and documentation, escalating anything outside its confidence threshold to the clinical operations team.
Book a demo tailored to your work — literature surveillance, submissions, or trial support.